ReAx Biotechnologies
2 known investors
Find your way into ReAx Biotechnologies
Sign up to see every warm intro you have to ReAx Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ReAx Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.
Founders & leadership
Investors · 2
OMX Ventureslisted by OMX VenturesLincolnshire
How we know: OMX Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does ReAx Biotechnologies do?
- Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.
- Who founded ReAx Biotechnologies?
- ReAx Biotechnologies was founded by Jeff Montgomery.
- Who are ReAx Biotechnologies's investors?
- ReAx Biotechnologies's investors include OMX Ventures, Portal Innovations.


